Erik van den Berg

Erik van den Berg

Directeur Général chez
AM-Pharma Holding BV
53 ans
Health Technology
Commercial Services
Consumer Services

Profil

Erik J.
van den Berg
was the founder of HeatMatrix Group BV, founded in 2008, where the title held was Director.
Mr. van den Berg was the founder of LAVA Therapeutics NV, founded in 2016, where the title held was Independent Non-Executive Director from 2021 to 2022.
Current jobs include Chief Executive Officer at AM-Pharma Holding BV; Chief Executive Officer & Director at Memo Therapeutics AG since 2023; Chairman at Step Pharma SAS since 2016; Director at Lead Pharma Holding BV since 2016; Director at Tridek-One Therapeutics SAS; and Member-Supervisory Board at AM-Pharma BV since 2007.
Former jobs include Principal at IsoTis, Inc.; Management Consultant at Arthur D.
Little, Inc.; and Principal at Organon International, Inc. Education includes graduate studies at the University of Utrecht and an MBA from Manchester Business School.

Postes actifs de Erik van den Berg

SociétésPosteDébut
Directeur/Membre du Conseil -
Directeur Général -
Président -
Directeur/Membre du Conseil 01/03/2016
Directeur/Membre du Conseil -
Directeur Général 16/11/2023

Anciens postes connus de Erik van den Berg

SociétésPosteFin
LAVA THERAPEUTICS Fondateur 15/06/2022
Fondateur -
Corporate Officer/Principal -
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░ ░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Erik van den Berg

Formation de Erik van den Berg

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

17

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Producer Manufacturing

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Erik van den Berg
🔇